A Phase III Randomized Study of Taxotere 75/mg/M2 vs. ALIMTA for Second-line Chemo for Non-Small Cell Lung Cancer

Abstracts/Posters/Presentations:

• Nasser Hanna, Frances A Shepherd, Rafael Rosell, Jose R Pereira, Filippo De Marinis, Frank V Fossella, Louis Kayitalire, Sofia Paul, Lawrence Einhorn, Paul A Bunn. A Phase III Study of Pemetrexed vs Docetaxel in Patients with Recurrent Non-Small Cell Lung Cancer (NSCLC) who were Previously Treated with Chemotherapy): A Hoosier Oncology Group Study LUN01-15. Presented at the ASCO annual meeting May 31-June 3, 2003, Chicago, IL

Manuscripts/Articles:

• Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, Gatzemeier U, Tsao TC, Pless M, Muller T, Lim HL, Desch C, Szondy K, Gervais R, Shaharyar, Manegold C, Paul S, Paoletti P, Einhorn L, Bunn PA Jr. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol. 2004 May 1;22(9):1589-97. See abstract.